Creating Your Own Customers
Forward integration into the service sector may be right for a select number of medical product companies, but many such mergers fail. Services require dramatically different core competencies and prospective customers may view the product company as a competitor. The few successes highlight the strategies' hurdles.
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
A busy October will include planned biosimilar launches and key appointments for the off-patent sector.
Sandoz has had its say on its biosimilar rivals with largely branded portfolios, as well as the recent EMA statement supporting biosimilar interchangeability.